Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Massachusetts › Boston
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Boston, MA
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
RecruitingPhase 1
- Boston Children's Hospital, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in other cities
- Houston, TX8 studies
- New York City, NY6 studies
- Columbus, OH5 studies
- Philadelphia, PA4 studies
- Washington, DC4 studies
- Staten Island, NY3 studies
- St. Louis, MO3 studies
- Queens, NY3 studies
- Baldwin Park, CA3 studies
- Edison, NJ3 studies
- East Norwalk, CT3 studies
- New Rochelle, NY3 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer60 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.